Crossmark

125I inhibits the progression of cervical cancer by upregulating the HSF1/PU.1/SYK signaling pathway and consequently enhancing the apoptotic response mediated by ROS/USP7/P53

Crossref DOI link: https://doi.org/10.1038/s41598-025-99214-2

Published Online: 2025-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fan, Xiaomei

Liang, Xiaoliang

Guo, Yunfeng

Jin, Ge

Ming, Dong

An, Xingwei
License Information

Text and Data Mining valid from 2025-05-21

Version of Record valid from 2025-05-21
More Information

Article History

Received: 9 August 2024

Accepted: 17 April 2025

First Online: 21 May 2025

Declarations

:

: The authors declare no competing interests.

: This study has been reviewed and approved by the Animal Welfare Ethics Committee of the Fourth Hospital of Hebei Medical University (No.20230305).

Document is current

Any future updates will be listed below